Zurcal 40 mg - 28 Gastro-Resistant Tablets

Zurcal 40 mg - 28 Gastro-Resistant Tablets

Description:

Zurcal 40 mg gastro-resistant tablets are a prescription medicine containing pantoprazole, a proton pump inhibitor (PPI) used to reduce excessive stomach acid. Each tablet is designed with a gastro-resistant coating to ensure the active ingredient is released in the intestine rather than the stomach, improving efficacy and tolerability. Zurcal 40 mg is commonly used in the treatment of acid-related disorders such as gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), and conditions associated with pathological hypersecretion of gastric acid. It is suitable for adult patients when prescribed by a healthcare professional.

Indications:

• Treatment of gastroesophageal reflux disease (GERD), including reflux esophagitis (inflammation of the esophagus caused by acid reflux).
• Symptomatic relief of heartburn, acid regurgitation, and epigastric pain associated with increased gastric acid secretion.
• Treatment of gastric and duodenal ulcers.
• Prevention of relapse of gastric or duodenal ulcers in patients requiring long-term acid suppression (as directed by a physician).
• Management of Zollinger–Ellison syndrome and other pathological hypersecretory conditions where there is excessive gastric acid production.
• Adjunctive therapy in combination with appropriate antibiotics for eradication of Helicobacter pylori in H. pylori–associated peptic ulcer disease (as per physician’s regimen).

Active Ingredients / Key Components:

• Pantoprazole sodium sesquihydrate – equivalent to pantoprazole 40 mg per gastro-resistant tablet.
• Other excipients and coating components (including gastro-resistant coating agents) are present but specific excipient details and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Adults: The usual recommended dose for GERD and reflux esophagitis is 40 mg (one tablet) once daily, as prescribed by the physician.
• For gastric or duodenal ulcers, the typical dose is 40 mg once daily; in some cases, the doctor may increase to 40 mg twice daily for severe or resistant cases.
• For Zollinger–Ellison syndrome and other hypersecretory conditions, dosing is individualized and may start at 40 mg twice daily, adjusted by the physician according to response.
• For H. pylori eradication (in combination therapy), pantoprazole 40 mg is usually taken twice daily with appropriate antibiotics, following the exact regimen prescribed by the doctor.
• Tablets should be swallowed whole with water; do not crush, chew, or break the tablet to preserve the gastro-resistant coating.
• Take preferably before a meal (usually in the morning, or morning and evening if twice daily), as directed by your healthcare provider.
• Duration of treatment varies: typically 2–4 weeks for duodenal ulcers, 4–8 weeks for gastric ulcers and reflux esophagitis, and longer for chronic conditions as directed by the physician.
• Do not exceed the prescribed dose or duration without medical supervision.

Clinical Benefits:

• Effectively reduces gastric acid secretion by irreversibly inhibiting the gastric proton pump (H+ / K+ ATPase) in stomach parietal cells.
• Promotes healing of gastric and duodenal ulcers and reduces the risk of ulcer recurrence when used appropriately.
• Provides sustained relief from heartburn, acid reflux, and related symptoms of GERD, improving comfort and quality of life.
• Helps protect the esophageal and gastric mucosa from acid-related damage, reducing inflammation and irritation.
• Supports management of severe acid hypersecretion conditions such as Zollinger–Ellison syndrome under specialist supervision.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to pantoprazole, other proton pump inhibitors, or any component of the formulation.
• Not recommended for use in children unless specifically prescribed by a pediatric specialist (pediatric dosing information is not provided here).
• Use with caution in patients with severe liver impairment; dose adjustment or monitoring may be required. Inform your doctor if you have liver disease.
• Long-term use of proton pump inhibitors may be associated with increased risk of bone fractures (hip, wrist, spine), especially in older adults or those with other risk factors; ensure adequate calcium and vitamin d intake as advised by your doctor.
• Prolonged therapy may be associated with low magnesium levels (hypomagnesemia), vitamin b12 deficiency, and increased risk of certain infections such as Clostridioides difficile–associated diarrhea; periodic monitoring may be needed for long-term users.
• Seek medical advice if you experience alarm symptoms such as unintentional weight loss, persistent vomiting, difficulty swallowing, vomiting blood, or black stools before or during treatment.
• Consult your doctor before use if pregnant or planning pregnancy; pantoprazole should be used during pregnancy only if clearly needed and prescribed. Discuss risks and benefits with your healthcare provider.
• Consult your doctor before use if breastfeeding; pantoprazole may pass into breast milk and a decision should be made whether to discontinue nursing or the drug.
• Inform your doctor about all medications you are taking, especially anticoagulants (e.g., warfarin), antiretrovirals (e.g., atazanavir), methotrexate (especially high doses), antifungals, or other drugs that may interact with acid suppression therapy.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, dizziness, abdominal pain, diarrhea, constipation, flatulence, nausea, or vomiting.
• Less common side effects can include dry mouth, rash, itching, or sleep disturbances.
• Serious but rare side effects may include severe allergic reactions (swelling of face, lips, tongue, or throat, difficulty breathing), severe skin reactions, jaundice or signs of liver problems (yellowing of skin or eyes, dark urine), severe diarrhea, or muscle cramps associated with low magnesium.
• Stop using the product and seek immediate medical attention if you experience signs of a severe allergic reaction, chest pain, severe abdominal pain, or any other unusual or worrying symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature recommended on the product packaging (specific temperature range is not available in the provided information).

Specifications:

• Product type: Prescription medicine – proton pump inhibitor (pantoprazole).
• Strength: 40 mg pantoprazole per gastro-resistant tablet.
• Form: Gastro-resistant tablet (film-coated, delayed-release).
• Pack size: 28 gastro-resistant tablets per pack.
• Intended use: Adults (and adolescents only if prescribed) for treatment of acid-related gastrointestinal disorders.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.